CONTENTS LETTER FROM NOEL WALLACE LETTER FROM ANN TRACY 2025 SUSTAINABILITY STRATEGY SUSTAINABILITY HIGHLIGHTS SUSTAINABILITY MANAGEMENT SUSTAINABILITY GOVERNANCE DRIVING SOCIAL IMPACT HELPING MILLIONS OF HOMES PRESERVING OUR ENVIRONMENT In 2021, we also joined the Chemical Footprint Project developed by Clean Production Action to measure our footpri nt globally. The Chemical Footprint Project is aligned with the following United Nations Sustainable Development Goals: Good Health and Wellbeing, Clean Water and Sanitation and Responsible Consumption and Production. Examples of more sustainable products include Palmolive products formulated with ingredients that meet stringent s afety criteria and performance standards and have earned EPA Safer Choice certification. We offer these products in both fragrance and fragrance-free versions so that consumers can make their preferred choice. For more information, see Safer Choice program | Palmolive® Promise. Product Safety The safety of our consumers and our people is our first and greatest concern. Our technical teams conduct rigorous safety evaluations on all our products before we bring them to the marketplace and ensure our products comply with, and often exceed, all applicable regulatory requirements wherever we do business. We work with regulatory agencies worldwide including the U.S. Food and Drug Administration (FDA), European Medicines Agency (EMA), World Health Organization (WHO) and Health Canada to ensure our products meet the highest standards of safety—for both people and the environment. Safety Evaluation Process When we introduce new products or ingredients in our products, we apply the following rigorous evaluation process to ensure tha t the products or ingredients are safe, all applicable regulations are followed, and our consumers are info rmed about these ingredients. Assess: Before we use a new ingredient, we complete a thorough safety ass essment of the ingredient for both its intended use and foreseeable misuse. If the ingredient is found to be unsafe, we will not use it. Develop: If the ingredient is determined safe, we move forward with dev eloping a product using the new ingredient and evaluate the product’s efficacy and potential adverse effects of its usage. If the resulting product does not meet our standards, we go back to the drawing board. Instruct: In the third stage, we ensure that proper warnings and use ins tructions are communicated on the label of the product. Monitor: It is our responsibility to continue to ensure the safety of our prod ucts once they are available to purchase. Our pharmacovigilance team—made up of physicians, pharmacists and nurses—gathers information on adverse effects and quality complaints from health care professionals and via consumer phone calls, social media, mail, clinical trials, market research and literature. After collecting and documenting that information, the team assesses and analyzes it to ensure that a product’s quality and safety is maintained throughout its lifecycle. PAGE 47 2021 SUSTAINABILITY AND SOCIAL IMPACT REPORT